{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:40:40Z","timestamp":1773142840648,"version":"3.50.1"},"reference-count":99,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS086134"],"award-info":[{"award-number":["NS086134"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK36729"],"award-info":[{"award-number":["DK36729"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS064330"],"award-info":[{"award-number":["NS064330"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007172","name":"Cincinnati Children's Hospital Medical Center","doi-asserted-by":"publisher","award":["Research Innovative Pilot Award 2015"],"award-info":[{"award-number":["Research Innovative Pilot Award 2015"]}],"id":[{"id":"10.13039\/100007172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007172","name":"Cincinnati Children's Hospital Medical Center","doi-asserted-by":"publisher","award":["Research Innovative Pilot Award"],"award-info":[{"award-number":["Research Innovative Pilot Award"]}],"id":[{"id":"10.13039\/100007172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162367","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T13:44:08Z","timestamp":1473169448000},"page":"e0162367","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Mei","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Liou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Swope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venette","family":"Inskeep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"key":"ref1","article-title":"The Online Metabolic and Molecular Bases of Inherited Diseases","author":"GA Grabowski","year":"2010"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1203\/00006450-200008000-00018","article-title":"Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation","volume":"48","author":"E Orvisky","year":"2000","journal-title":"Pediatr Res"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","article-title":"Enhanced calcium release in the acute neuronopathic form of Gaucher disease","volume":"18","author":"D Pelled","year":"2005","journal-title":"Neurobiology of disease"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2014.08.011","article-title":"CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings","volume":"114","author":"TA Burrow","year":"2015","journal-title":"Molecular genetics and metabolism"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"V Koprivica","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"KS Hruska","year":"2008","journal-title":"Human mutation"},{"issue":"Suppl 1","key":"ref7","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1002\/ajh.24063","article-title":"Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry","volume":"90","author":"GA Grabowski","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.braindev.2005.04.005","article-title":"Type 2 Gaucher disease: 15 new cases and review of the literature","volume":"28","author":"C Mignot","year":"2006","journal-title":"Brain Dev"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-010-9072-z","article-title":"Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy","volume":"33","author":"J Marshall","year":"2010","journal-title":"Journal of inherited metabolic disease"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/17425247.3.6.771","article-title":"Delivery of lysosomal enzymes for therapeutic use: glucocerebrosidase as an example","volume":"3","author":"GA Grabowski","year":"2006","journal-title":"Expert opinion on drug delivery"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"JR Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"72","author":"WC Nichols","year":"2009","journal-title":"Neurology"},{"issue":"17","key":"ref13","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1212\/WNL.0b013e3181b28601","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"73","author":"E Sidransky","year":"2009","journal-title":"Neurology"},{"issue":"17","key":"ref14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"E Sidransky","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"V Cullen","year":"2011","journal-title":"Ann Neurol"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/mds.22538","article-title":"The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism","volume":"24","author":"J DePaolo","year":"2009","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson's disease in type 1 Gaucher disease","volume":"33","author":"G Bultron","year":"2010","journal-title":"Journal of inherited metabolic disease"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp-2012-302402","article-title":"A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers","volume":"83","author":"A McNeill","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease","volume":"20","author":"S Lesage","year":"2011","journal-title":"Human molecular genetics"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"E Sidransky","year":"2012","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"ref21","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/ajh.24057","article-title":"Gaucher disease and comorbidities: B-cell malignancy and parkinsonism","volume":"90","author":"TM Cox","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"M Anheim","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"MW Cleeter","year":"2013","journal-title":"Neurochemistry international"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","article-title":"Mitochondria and quality control defects in a mouse model of Gaucher disease\u2014links to Parkinson's disease","volume":"17","author":"LD Osellame","year":"2013","journal-title":"Cell metabolism"},{"issue":"15","key":"ref25","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/hmg\/ddu105","article-title":"Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice","volume":"23","author":"YH Xu","year":"2014","journal-title":"Human molecular genetics"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10545-010-9095-5","article-title":"The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)","volume":"33","author":"P Cherin","year":"2010","journal-title":"Journal of inherited metabolic disease"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10545-008-0832-y","article-title":"'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature","volume":"31","author":"M Biegstraaten","year":"2008","journal-title":"Journal of inherited metabolic disease"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","article-title":"The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations","volume":"65","author":"O Goker-Alpan","year":"2008","journal-title":"Arch Neurol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"YH Xu","year":"2003","journal-title":"Am J Pathol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2013.12.003","article-title":"Neuroinflammation and alpha-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction","volume":"111","author":"EI Ginns","year":"2014","journal-title":"Molecular genetics and metabolism"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2013.03.006","article-title":"Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease","volume":"51","author":"A Sanders","year":"2013","journal-title":"Blood cells, molecules & diseases"},{"issue":"29","key":"ref32","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"SP Sardi","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/hmg\/ddt096","article-title":"Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice","volume":"22","author":"Y Sun","year":"2013","journal-title":"Human molecular genetics"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"e57560","DOI":"10.1371\/journal.pone.0057560","article-title":"Substrate compositional variation with tissue\/region and Gba1 mutations in mouse models\u2014implications for Gaucher disease","volume":"8","author":"Y Sun","year":"2013","journal-title":"PLoS One"},{"issue":"47","key":"ref35","doi-asserted-by":"crossref","first-page":"19958","DOI":"10.1073\/pnas.0908528106","article-title":"Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome","volume":"106","author":"D Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","article-title":"Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome","volume":"1188","author":"D Pan","year":"2008","journal-title":"Brain Res"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"e16187","DOI":"10.1371\/journal.pone.0016187","article-title":"Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency","volume":"6","author":"MR Skelton","year":"2011","journal-title":"PLoS One"},{"issue":"7277","key":"ref38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/463036a","article-title":"Neuroscience: Editing out fear","volume":"463","author":"GJ Quirk","year":"2010","journal-title":"Nature"},{"key":"ref39","article-title":"Current Protocols in Neuroscience","author":"RJ Carter","year":"2001"},{"issue":"Suppl","key":"ref40","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejim.2006.07.005","article-title":"Epidemiology and natural history of Gaucher's disease","volume":"17","author":"A Mehta","year":"2006","journal-title":"Eur J Intern Med"},{"issue":"18","key":"ref41","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"J Charrow","year":"2000","journal-title":"Arch Intern Med"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"e116023","DOI":"10.1371\/journal.pone.0116023","article-title":"Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model","volume":"9","author":"S Barnes","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"e10750","DOI":"10.1371\/journal.pone.0010750","article-title":"Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model","volume":"5","author":"YH Xu","year":"2010","journal-title":"PLoS One"},{"issue":"18","key":"ref44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","article-title":"Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study","volume":"78","author":"RN Alcalay","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort","volume":"72","author":"M Beavan","year":"2015","journal-title":"JAMA Neurol"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0004.1982.tb01445.x","article-title":"Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III","volume":"22","author":"O Nilsson","year":"1982","journal-title":"Clinical genetics"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype","volume":"76","author":"E Orvisky","year":"2002","journal-title":"Molecular genetics and metabolism"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","article-title":"Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3","volume":"14","author":"UH Schueler","year":"2003","journal-title":"Neurobiology of disease"},{"issue":"26","key":"ref49","doi-asserted-by":"crossref","first-page":"23594","DOI":"10.1074\/jbc.M300212200","article-title":"Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms","volume":"278","author":"E Lloyd-Evans","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"31","key":"ref50","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"E Korkotian","year":"1999","journal-title":"The Journal of biological chemistry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"DC Schondorf","year":"2014","journal-title":"Nat Commun"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4161\/auto.25878","article-title":"Defective quality control mechanisms and accumulation of damaged mitochondria link Gaucher and Parkinson diseases","volume":"9","author":"LD Osellame","year":"2013","journal-title":"Autophagy"},{"issue":"1\u20132","key":"ref53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2015.06.030","article-title":"Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease","volume":"356","author":"C Noelker","year":"2015","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"ref54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2011.06.008","article-title":"Aggregation of alpha-synuclein in brain samples from subjects with glucocerebrosidase mutations","volume":"104","author":"JH Choi","year":"2011","journal-title":"Molecular genetics and metabolism"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"K Wong","year":"2004","journal-title":"Molecular genetics and metabolism"},{"issue":"Pt 12","key":"ref56","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"I Fishbein","year":"2014","journal-title":"Brain"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2012.11.010","article-title":"Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity","volume":"108","author":"TL Yap","year":"2013","journal-title":"Molecular genetics and metabolism"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"YH Xu","year":"2011","journal-title":"Molecular genetics and metabolism"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: teammates in neurodegeneration?","volume":"9","author":"S Moussaud","year":"2014","journal-title":"Mol Neurodegener"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies","volume":"78","author":"U Sengupta","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"21","key":"ref61","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"LK Clinton","year":"2010","journal-title":"J Neurosci"},{"issue":"5619","key":"ref62","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"BI Giasson","year":"2003","journal-title":"Science"},{"issue":"2","key":"ref63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2004.01.007","article-title":"Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation","volume":"187","author":"PT Kotzbauer","year":"2004","journal-title":"Exp Neurol"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cell.2011.10.009","article-title":"Molecular mechanisms of fear learning and memory","volume":"147","author":"JP Johansen","year":"2011","journal-title":"Cell"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"JE LeDoux","year":"2000","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","article-title":"Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?","volume":"65","author":"MS Fanselow","year":"2010","journal-title":"Neuron"},{"issue":"12","key":"ref67","doi-asserted-by":"crossref","first-page":"e115765","DOI":"10.1371\/journal.pone.0115765","article-title":"Tau reduction diminishes spatial learning and memory deficits after mild repetitive traumatic brain injury in mice","volume":"9","author":"JS Cheng","year":"2014","journal-title":"PLoS One"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroscience.2015.11.009","article-title":"Using mice to model Obsessive Compulsive Disorder: From genes to circuits","volume":"321","author":"SE Ahmari","year":"2016","journal-title":"Neuroscience"},{"issue":"5\u20136","key":"ref69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000321190","article-title":"Pharmacologically distinctive behaviors other than burying marbles during the marble burying test in mice","volume":"86","author":"E Hayashi","year":"2010","journal-title":"Pharmacology"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1203\/00006450-199805000-00003","article-title":"Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease","volume":"43","author":"N Tayebi","year":"1998","journal-title":"Pediatr Res"},{"key":"ref71","article-title":"Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model","author":"N Dasgupta","year":"2015","journal-title":"Human molecular genetics"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1203\/01.PDR.0000049515.79882.94","article-title":"Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup","volume":"53","author":"JK Park","year":"2003","journal-title":"Pediatr Res"},{"issue":"3","key":"ref73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/14737175.6.3.407","article-title":"Gender disparities in Parkinson's disease","volume":"6","author":"LM Shulman","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e1175","DOI":"10.7717\/peerj.1175","article-title":"A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease","volume":"3","author":"WJ Geldenhuys","year":"2015","journal-title":"PeerJ"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2014.06.048","article-title":"Heterozygous mice deficient in Atp1a3 exhibit motor deficits by chronic restraint stress","volume":"272","author":"H Sugimoto","year":"2014","journal-title":"Behav Brain Res"},{"issue":"42","key":"ref76","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"SM Fleming","year":"2004","journal-title":"J Neurosci"},{"issue":"2","key":"ref77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbr.2004.08.019","article-title":"Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA)","volume":"158","author":"KM Hemsley","year":"2005","journal-title":"Behav Brain Res"},{"issue":"1","key":"ref78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.05.079","article-title":"Characterization of a C57BL\/6 congenic mouse strain of mucopolysaccharidosis type IIIA","volume":"1104","author":"AC Crawley","year":"2006","journal-title":"Brain Res"},{"issue":"11","key":"ref79","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/hmg\/10.11.1191","article-title":"A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse","volume":"10","author":"J Matsuda","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"16","key":"ref80","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1073\/pnas.1531957100","article-title":"Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol","volume":"100","author":"E Vegeto","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref81","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Y Sun","year":"2010","journal-title":"Human molecular genetics"},{"issue":"2","key":"ref82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2008.01.013","article-title":"Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels","volume":"94","author":"YH Xu","year":"2008","journal-title":"Molecular genetics and metabolism"},{"issue":"5","key":"ref83","doi-asserted-by":"crossref","first-page":"e2296","DOI":"10.1371\/journal.pone.0002296","article-title":"Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice","volume":"3","author":"J Ausseil","year":"2008","journal-title":"PLoS One"},{"issue":"25","key":"ref84","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","article-title":"Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy","volume":"93","author":"B Hess","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref85","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0306-4522(01)00517-6","article-title":"Neurodegeneration in the Niemann-Pick C mouse: glial involvement","volume":"109","author":"DC German","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"ref86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0018-506X(02)00022-3","article-title":"Chronic stress effects on memory: sex differences in performance and monoaminergic activity","volume":"43","author":"RE Bowman","year":"2003","journal-title":"Horm Behav"},{"issue":"3","key":"ref87","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neulet.2005.04.037","article-title":"Chronic-stress induced modulation of different states of anxiety-like behavior in female rats","volume":"383","author":"R Mitra","year":"2005","journal-title":"Neurosci Lett"},{"issue":"3","key":"ref88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/1025389021000010549","article-title":"Sex differences in chronic stress effects on memory in rats","volume":"5","author":"V Luine","year":"2002","journal-title":"Stress"},{"issue":"3","key":"ref89","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0306-4522(97)00233-9","article-title":"Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress","volume":"81","author":"LA Galea","year":"1997","journal-title":"Neuroscience"},{"issue":"3","key":"ref90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0029-1216276","article-title":"Sex, sex steroids, and brain injury","volume":"27","author":"PS Herson","year":"2009","journal-title":"Semin Reprod Med"},{"issue":"13","key":"ref91","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1073\/pnas.1300065110","article-title":"O-GlcNAc transferase (OGT) as a placental biomarker of maternal stress and reprogramming of CNS gene transcription in development","volume":"110","author":"CL Howerton","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13059-015-0591-7","article-title":"Copy number variation in Y chromosome multicopy genes is linked to a paternal parent-of-origin effect on CNS autoimmune disease in female offspring","volume":"16","author":"LK Case","year":"2015","journal-title":"Genome Biol"},{"issue":"6","key":"ref93","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/MOP.0b013e3282f161f2","article-title":"Enzyme reconstitution\/replacement therapy for lysosomal storage diseases","volume":"19","author":"TA Burrow","year":"2007","journal-title":"Current opinion in pediatrics"},{"issue":"1","key":"ref94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bcmd.2001.0477","article-title":"Early-onset severe neurological involvement and D409H homozygosity in Gaucher disease: outcome of enzyme replacement therapy","volume":"28","author":"H Michelakakis","year":"2002","journal-title":"Blood cells, molecules & diseases"},{"issue":"6","key":"ref95","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.E049817","article-title":"Thematic review series: Recent advances in the treatment of lysosomal storage diseases","volume":"55","author":"JA Shayman","year":"2014","journal-title":"Journal of lipid research"},{"issue":"8","key":"ref96","doi-asserted-by":"crossref","first-page":"e43310","DOI":"10.1371\/journal.pone.0043310","article-title":"Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease","volume":"7","author":"MA Cabrera-Salazar","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"ref97","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/mt.2014.152","article-title":"Normalization and improvement of CNS deficits in mice with hurler syndrome after long-term peripheral delivery of BBB-targeted iduronidase","volume":"22","author":"SS El-Amouri","year":"2014","journal-title":"Mol Ther"},{"issue":"5","key":"ref98","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/emmm.201202083","article-title":"A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA","volume":"5","author":"NC Sorrentino","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"8","key":"ref99","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"D Wang","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:03:58Z","timestamp":1588968238000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162367"}},"subtitle":[],"editor":[{"given":"Huaibin","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":99,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162367","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}